Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00002055 · ClinicalTrials.gov registry record · NA

A Double-Blind Group Comparative Study To Evaluate the Long-Term Safety and Effectiveness of Two Different Doses of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients With Multiple Episodes of PCP

A NA study of HIV Infections and Pneumonia, Pneumocystis Carinii, sponsored by Fisons.

Completed
Registry status
NA
Development phase
4
Study locations

NCT00002055: Completed NA study of HIV Infections and Pneumonia, Pneumocystis Carinii, sponsored by Fisons.

NCT00002055 is a NA study of HIV Infections and Pneumonia, Pneumocystis Carinii that has completed, run by Fisons. The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00002055, a NA study of HIV Infections and Pneumonia, Pneumocystis Carinii, has completed, sponsored by Fisons.

COMPLETED
Registry status
NA
Development phase
4
Study locations

Study Summary

To evaluate and compare the safety, tolerability, and effectiveness of long-term biweekly administration of 1 of 2 doses of aerosol pentamidine when used as a prophylactic agent in patients who have had multiple episodes of AIDS associated Pneumocystis carinii pneumonia (PCP).

Conditions Studied

HIV Infections Pneumonia, Pneumocystis Carinii

Interventions

  • DRUG Pentamidine isethionate

Study Locations (4)

District of Columbia

  • Georgetown Univ - Washington D.C.
  • Veterans Administration Med Ctr - Washington D.C.

Illinois

  • Northwestern Univ Med School - Chicago

Massachusetts

  • Beth Israel Deaconess - West Campus - Boston

Trial Details

FieldValue
Phase NA
Fisons

5 total trials

What the finished NCT00002055 record still lists

NCT00002055 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.

The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Pentamidine isethionate is the first listed.

NCT00002055 reports a single indexed study location in District of Columbia, Illinois, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00002055 about?

NCT00002055 is a clinical study titled "A Double-Blind Group Comparative Study To Evaluate the Long-Term Safety and Effectiveness of Two Different Doses of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients With Multiple Episodes of PCP". To evaluate and compare the safety, tolerability, and effectiveness of long-term biweekly administration of 1 of 2 doses of aerosol pentamidine when used as a prophylactic agent in patients who have had multiple episodes of AIDS associated Pneumocystis carinii pneumonia (PCP).

What is the current status of trial NCT00002055?

This trial is currently completed. It is a NA study.

What conditions does trial NCT00002055 study?

This clinical trial studies the following conditions: HIV Infections, Pneumonia, Pneumocystis Carinii.

What interventions are being tested in trial NCT00002055?

The interventions under investigation include: Pentamidine isethionate (DRUG).

Who is sponsoring clinical trial NCT00002055?

This trial is sponsored by Fisons, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00002055 being conducted?

This trial has 4 study locations across District of Columbia, Illinois, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Related registry views

Source: ClinicalTrials.gov NCT00002055, the US trial registry maintained by the National Library of Medicine. NCT00002055 (unsized enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.